Respadd, in partnership with Ofma and the Ceip-Addictovigilance Association, has just published a new guide "opioid analgesic drugs: what you need to know, what to do". "Unlimited pain medication prescriptions during the 1990s in the US culminated in the Purdue Pharma campaign to market OxyContin. Combined with the rise of heroin, especially black tar, 20 years later, more than 70,000 deaths from annual overdoses, one for every 4,500 residents. This tragedy resulted in forensic medicine sending a letter to the prescribing doctor, telling them that, statistically, one of their patients who had previously prescribed opioids had died the previous year of drug overdose, "recalled Anne Borgne, president of Respadd, in her introduction to the guide. "This health crisis demonstrates the importance of the independence of caregivers from the drug industry and the need to address individual health determinants by strengthening the health skills and knowledge of both patients and those around them." from all health professionals, "he explained." Acting in health promotion, a prerequisite for promoting virtuous health behavior, early intervention in risk situations, promoting autonomy and allowing all choices based on evidence based information. This is the challenge of this new publication by Respadd, which offers information professionals that they need for the use of good opioid analgesic drugs, in an accessible format, highlighting the knowledge and actions that flow from it. "Meanwhile, Professor Nicolas Authier, director The French Observatory for Analgesic Drugs, recalling in the introduction in the same book that "opioid analgesics are consumed by around 12 million French people every year". "Although exposure to drugs of this class is relatively stable for more than ten years, the evolution of hospitalization for analgesic intoxication opioids and deaths increased significantly in France, "the doctor noted. He also warned that the number of French people treated with strong opioid analgesics (morphine, fentanyl or oxycodone) also almost doubled in the past ten years, especially for unrelated pain with cancer (…) This is the role of each health actor for uk participate in appropriate use and inform the French pharmacosurveillance system (…) complications associated with these drugs, the most serious are addiction or overdose ", then the release of this guide which is" very important to provide health professionals with important information about these medicines to prescribe them and accompany them to give good practice advice. "